{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:42:57Z","timestamp":1780638177571,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"DOI":"10.1007\/s12105-024-01743-1","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T04:02:17Z","timestamp":1739764937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinicopathological and Immunohistochemical Risk Predictors for Ameloblastoma Recurrence"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6622-511X","authenticated-orcid":false,"given":"H\u00e9vila de Figueiredo","family":"Pires","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0483-6601","authenticated-orcid":false,"given":"Gl\u00f3ria Maria de","family":"Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-3465","authenticated-orcid":false,"given":"Hannah Gil de Farias","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0430-4656","authenticated-orcid":false,"given":"Weslay Rodrigues da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7577-5375","authenticated-orcid":false,"given":"Roseana de Almeida","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1092-1992","authenticated-orcid":false,"given":"H\u00e9bel Cavalcanti","family":"Galv\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"1743_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12105-021-01404-7","volume":"16","author":"M Vered","year":"2022","unstructured":"Vered M, Wright JM (2022) Update from the 5th Edition of the World Health Organization Classification of Head and Neck tumors: odontogenic and maxillofacial bone tumours. Head Neck Pathol 16:63\u201375. https:\/\/doi.org\/10.1007\/s12105-021-01404-7","journal-title":"Head Neck Pathol"},{"issue":"5","key":"1743_CR2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00428-018-2305-5","volume":"472","author":"SE G\u00fcltekin","year":"2018","unstructured":"G\u00fcltekin SE, Aziz R, Heydt C, Seng\u00fcven B, Z\u00f6ller J, Safi AF, Kreppel M, Buettner R (2018) The landscape of genetic alterations in ameloblastomas relates to clinical features. Virchows Arch 472(5):807\u2013814. https:\/\/doi.org\/10.1007\/s00428-018-2305-5","journal-title":"Virchows Arch"},{"issue":"1","key":"1743_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/odi.13031","volume":"26","author":"FN Hendra","year":"2020","unstructured":"Hendra FN, Van Cann EM, Helder MN, Ruslin M, de Visscher JG, Forouzanfar T, Vet HCW (2020) Global incidence and profile of ameloblastoma: a systematic review and meta-analysis. Oral Dis 26(1):12\u201321. https:\/\/doi.org\/10.1111\/odi.13031","journal-title":"Oral Dis"},{"issue":"1\u20132","key":"1743_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/odi.12702","volume":"24","author":"M Kreppel","year":"2018","unstructured":"Kreppel M, Z\u00f6ller J (2018) Ameloblastoma-Clinical, radiological, and therapeutic findings. Oral Dis 24(1\u20132):63\u201366. https:\/\/doi.org\/10.1111\/odi.12702","journal-title":"Oral Dis"},{"issue":"3","key":"1743_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/odi.12646","volume":"24","author":"O Effiom","year":"2017","unstructured":"Effiom O, Ogundana O, Akinshipo A, Akintoye S (2017) Ameloblastoma: current etiopathological concepts and management. Oral Dis 24(3):307\u2013316. https:\/\/doi.org\/10.1111\/odi.12646","journal-title":"Oral Dis"},{"issue":"7","key":"1743_CR6","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1111\/odi.130145","volume":"25","author":"FN Hendra","year":"2019","unstructured":"Hendra FN, Natsir Kalla DS, Van Cann EM, de Vet HCW, Helder MN, Forouzanfar T (2019) Radical vs conservative treatment of intraosseous ameloblastoma: systematic review and meta-analysis. Oral Dis 25(7):1683\u20131696. https:\/\/doi.org\/10.1111\/odi.13014","journal-title":"Oral Dis"},{"issue":"14","key":"1743_CR7","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.7150\/ijms.61500","volume":"18","author":"L Bi","year":"2021","unstructured":"Bi L, Wei D, Hong D, Wang J, Qian K, Wang H, Zhu H (2021) A retrospective study of 158 cases on the risk factors for recurrence in ameloblastoma. Int J Med Sci 18(14):3326\u20133332. https:\/\/doi.org\/10.7150\/ijms.61500","journal-title":"Int J Med Sci"},{"issue":"10","key":"1743_CR8","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.ijom.2019.04.008","volume":"48","author":"SW \u200c \u200cAu","year":"2019","unstructured":"\u200c \u200cAu SW, Li KY, Choi WS, Su YX (2019) Risk factors for recurrence of ameloblastoma: a long-term follow-up retrospective study. Int J Oral Maxillofac Surg 48(10):1300\u20131306. https:\/\/doi.org\/10.1016\/j.ijom.2019.04.008","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"2","key":"1743_CR9","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.4317\/medoral.22210","volume":"23","author":"R Bologna-Molina","year":"2018","unstructured":"Bologna-Molina R, Pereira-Prado V, Sanchez-Romero C, Tapia-Repetto G, Soria S, Hernandez M, Gonzalez-Gonzalez R, Molina-Frechero M, Mikami T (2018) Expression of hMLH1 and hMSH2 proteins in ameloblastomas and tooth germs. Med Oral Patol Oral Cir Bucal 23(2):e126\u2013e131. https:\/\/doi.org\/10.4317\/medoral.22210","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"1743_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fmolb.2020.00122","volume":"26","author":"N Pe\u0107ina-\u0160laus","year":"2020","unstructured":"Pe\u0107ina-\u0160laus N, Kafka A, Salamon I, Bukovac A (2020) Mismatch repair pathway, genome stability and cancer. Front Mol Biosci 26:7:122. https:\/\/doi.org\/10.3389\/fmolb.2020.00122","journal-title":"Front Mol Biosci"},{"issue":"1","key":"1743_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.oooo.2015.03.011","volume":"120","author":"BBV Monteiro","year":"2015","unstructured":"Monteiro BBV, Cavalcante RB, Nogueira RLM, Miguel MMC, Nonaka CFW, Silveira \u00c9JD (2015) Participation of hMLH1, p63, and MDM2 proteins in the pathogenesis of syndromic and nonsyndromic keratocystic odontogenic tumors. Oral surgery, oral medicine. Oral Pathol Oral Radiol 120(1):52\u201357. https:\/\/doi.org\/10.1016\/j.oooo.2015.03.011","journal-title":"Oral Pathol Oral Radiol"},{"issue":"5","key":"1743_CR12","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/hed.24720","volume":"39","author":"R Yang","year":"2017","unstructured":"Yang R, Liu Z, Peng C, Cao W, Ji T (2017) Maxillary ameloblastoma: factors associated with risk of recurrence. Head Neck 39(5):996\u20131000. https:\/\/doi.org\/10.1002\/hed.24720","journal-title":"Head Neck"},{"issue":"3","key":"1743_CR13","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.oooo.2017.05.511","volume":"124","author":"GK Amaral-Silva","year":"2017","unstructured":"Amaral-Silva GK, S\u00e1nchez-Romero C, Wagner VP, Martins MD, Pontes HAR, Fregnani ER, Soares FA, Almeida OP, Rocha AC, Santos-Silva AR, Fonseca FP, Vargas PA (2017) Prognostic significance of hMSH2, hMSH3, and hMSH6 expression in ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 124(3):286\u2013295. https:\/\/doi.org\/10.1016\/j.oooo.2017.05.511","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"1743_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1186\/s12885-018-4802-y","volume":"18","author":"GS Fernandes","year":"2018","unstructured":"Fernandes GS, Girardi DM, Bernardes JPG, Fonseca FP, Fregnani ER (2018) Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation. BMC Cancer 18(1):887. https:\/\/doi.org\/10.1186\/s12885-018-4802-y","journal-title":"BMC Cancer"},{"issue":"1","key":"1743_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/adj.12244","volume":"60","author":"T Singh","year":"2015","unstructured":"Singh T, Wiesenfeld D, Clement J, Chandu A, Nastri A (2015) Ameloblastoma: demographic data and treatment outcomes from Melbourne, Australia. Aust Dent J 60(1):24\u201329. https:\/\/doi.org\/10.1111\/adj.12244","journal-title":"Aust Dent J"},{"issue":"1","key":"1743_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.anorl.2016.09.004","volume":"134","author":"A Laborde","year":"2017","unstructured":"Laborde A, Nicot R, Wojcik T, Ferri J, Raoul G (2017) Ameloblastoma of the jaws: management and recurrence rate. Eur Ann Otorhinolaryngol Head Neck Dis 134(1):7\u201311. https:\/\/doi.org\/10.1016\/j.anorl.2016.09.004","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"2","key":"1743_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jcms.2016.12.011","volume":"45","author":"F Jaeger","year":"2017","unstructured":"Jaeger F, Saturnino M, Silva FB, Soraya M, Alencar E, C\u00e1ssia M, Mesquita RA (2017) Prevalence profile of odontogenic cysts and tumors on Brazilian sample after the reclassification of odontogenic keratocyst. J Craniomaxillofac Surg 45(2):267\u2013270. https:\/\/doi.org\/10.1016\/j.jcms.2016.12.011","journal-title":"J Craniomaxillofac Surg"},{"key":"1743_CR18","doi-asserted-by":"publisher","unstructured":"de Medeiros W, da Silva L, Santos P, Pinto L, de Souza L (2018) Clinicopathological analysis of odontogenic tumors diseas 22 years period: Experience of a single center in northeastern Brazil. Med Oral Patol Oral Cir Bucal, 1;23(6):e664-e671. https:\/\/doi.org\/10.4317\/medoral.22618","DOI":"10.4317\/medoral.22618"},{"issue":"6","key":"1743_CR19","doi-asserted-by":"publisher","first-page":"e761","DOI":"10.4317\/medoral.22473","volume":"23","author":"B Aregbesola","year":"2018","unstructured":"Aregbesola B, Soyele O, Effiom O, Gbotolorun O, Taiwo O, Amole I (2018) Odontogenic tumours in Nigeria: a multicentre study of 582 cases and review of the literature. Med Oral Patol Oral Cir Bucal 23(6):e761\u2013e766. https:\/\/doi.org\/10.4317\/medoral.22473","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"2","key":"1743_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s12663-022-01694-6","volume":"21","author":"R Dandriyal","year":"2022","unstructured":"Dandriyal R, Lal V, Giri KY, Bavanthabettu NI, Chaurasia A, Pant S (2022) Ameloblastoma: Retrospective Study and Analysis of 102 cases over 10 years, single centre, institutional experience. J Oral Maxillofac Surg 21(2):730\u2013738. https:\/\/doi.org\/10.1007\/s12663-022-01694-6","journal-title":"J Oral Maxillofac Surg"},{"issue":"7","key":"1743_CR21","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00405-015-3631-8","volume":"273","author":"AC McClary","year":"2015","unstructured":"McClary AC, West RB, McClary AC, Pollack JR, Fischbein NJ, Holsinger CF, Sunwoo J, Colevas AD, Sirjani D (2015) Ameloblastoma: a clinical review and trends in management. Eur Arch Otorhinolaryngol 273(7):1649\u20131661. https:\/\/doi.org\/10.1007\/s00405-015-3631-8","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"1743_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12105-016-0734-5","volume":"10","author":"T Milman","year":"2016","unstructured":"Milman T, Ying G-S, Pan W, LiVolsi V (2016) Ameloblastoma: 25-year experience at a single institution. Head Neck Pathol 10(4):513\u2013520. https:\/\/doi.org\/10.1007\/s12105-016-0734-5","journal-title":"Head Neck Pathol"},{"issue":"1","key":"1743_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jcms.2016.10.013","volume":"45","author":"EA Al-Moraissi","year":"2017","unstructured":"Al-Moraissi EA, Dahan AA, Alwadeai MS, Oginni FO, Al-Jamali J, Alkhutari AS, Al-Tairi NH, Almaweri AA, Al-Sanabani JS (2017) What surgical treatment has the lowest recurrence rate following the management of keratocystic odontogenic tumor? A large systematic review and meta-analysis. J Craniomaxillofac Surg 45(1):131\u2013144. https:\/\/doi.org\/10.1016\/j.jcms.2016.10.013","journal-title":"J Craniomaxillofac Surg"},{"issue":"5","key":"1743_CR24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1034\/j.1600-0714.2001.300508.x","volume":"30","author":"G Castrilli","year":"2001","unstructured":"Castrilli G, Piantelli M, Artese L, Perfetti G, Rubini C, Fioroni M, Ranelletti FO, Piattelli A (2001) Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in ameloblastoma. J Oral Pathol Med 30(5):305\u2013308. https:\/\/doi.org\/10.1034\/j.1600-0714.2001.300508.x","journal-title":"J Oral Pathol Med"},{"issue":"5","key":"1743_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1034\/j.1600-0714.2001.300508.x","volume":"30","author":"GCM Piantelli","year":"2001","unstructured":"Piantelli GCM, Artese L, Perfetti G, Rubini C, Fioroni MRFO, Piattelli A (2001) Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in ameloblastoma. J Oral Pathol Med 30(5):305\u2013308. https:\/\/doi.org\/10.1034\/j.1600-0714.2001.300508.x","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"1743_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3802\/jgo.2015.26.1.40","volume":"26","author":"M Kato","year":"2015","unstructured":"Kato M, Takano M, Miyamoto M, Sasaki N, Goto T, Tsuda H, Furuya K (2015) DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers. J Gynecol Oncol 26(1):40\u201345. https:\/\/doi.org\/10.3802\/jgo.2015.26.1.40","journal-title":"J Gynecol Oncol"},{"issue":"22","key":"1743_CR27","doi-asserted-by":"publisher","first-page":"e3725","DOI":"10.1097\/MD.0000000000003725","volume":"95","author":"VP Wagner","year":"2016","unstructured":"Wagner VP, Webber LP, Salvadori G, Meurer L, Fonseca FP, Castilho RM, Squarize CH, Vargas PA, Martins MD (2016) Overexpression of MutS\u03b1 Complex proteins predicts poor prognosis in oral squamous cell carcinoma. Medicine 95(22):e3725. https:\/\/doi.org\/10.1097\/MD.0000000000003725","journal-title":"Medicine"},{"issue":"3","key":"1743_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1600-0714.2010.00945.x","volume":"40","author":"S Theocharis","year":"2011","unstructured":"Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, Point D, Tsourouflis G, Sastre-Garau X (2011) Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients\u2019. Survival J Oral Pathol Med 40(3):218\u2013226. https:\/\/doi.org\/10.1111\/j.1600-0714.2010.00945.x","journal-title":"Survival J Oral Pathol Med"},{"issue":"5","key":"1743_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.anorl.2015.08.016","volume":"132","author":"B Ahlem","year":"2015","unstructured":"Ahlem B, Wided A, Amani L, Nadia Z, Amira A, Faten F (2015) Study of Ki67 and CD10 expression as predictive factors of recurrence of ameloblastoma. Eur Ann Otorhinolaryngol Head Neck Dis 132(5):275\u20132799. https:\/\/doi.org\/10.1016\/j.anorl.2015.08.016","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"2","key":"1743_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/0964-1955(94)90064-7","volume":"30B","author":"J Kim","year":"1994","unstructured":"Kim J, Yook JI (1994) Immunohistochemical study on proliferating cell nuclear antigen expression in ameloblastomas. Eur J Cancer B Oral Oncol 30B(2):126\u2013131. https:\/\/doi.org\/10.1016\/0964-1955(94)90064-7","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"1743_CR31","doi-asserted-by":"publisher","unstructured":"Montezuma MAP, Fonseca FP, Benites BM, Soares CD, do, Amaral-Silva GK, de Almeida OP, Soares FA, Pagano RL, Fregnani ER (2018) COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma. Pathol Res Pract, 214(6), 907\u2013913. https:\/\/doi.org\/10.1016\/j.prp.2018.03.014","DOI":"10.1016\/j.prp.2018.03.014"},{"issue":"3","key":"1743_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/his.13095","volume":"70","author":"ER Fregnani","year":"2017","unstructured":"Fregnani ER, Perez DE, Paes de Almeida O, Fonseca FP, Soares FA, Castro-Junior G, Alves FA (2017) BRAF-V600E expression correlates with ameloblastoma aggressiveness. Histopathology 70(3):473\u2013484. https:\/\/doi.org\/10.1111\/his.13095","journal-title":"Histopathology"},{"issue":"5","key":"1743_CR33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/path.4317","volume":"232","author":"KJ Kurppa","year":"2014","unstructured":"Kurppa KJ, Cat\u00f3n J, Morgan PR, Ristim\u00e4ki A, Ruhin B, Kellokoski J, Elenius K, Heikinheimo K (2014) High frequency of BRAF V600E mutations in ameloblastoma. J Pathol 232(5):492\u2013498. https:\/\/doi.org\/10.1002\/path.4317","journal-title":"J Pathol"},{"issue":"10","key":"1743_CR34","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/jop.12443","volume":"45","author":"NB Pereira","year":"2016","unstructured":"Pereira NB, Pereira KM, Coura BP, Diniz MG, de Castro WH, Gomes CC, Gomez RS (2016) BRAFV600E mutation in the diagnosis of unicystic ameloblastoma. J Oral Pathol Med 45(10):780\u2013785. https:\/\/doi.org\/10.1111\/jop.12443","journal-title":"J Oral Pathol Med"},{"issue":"21","key":"1743_CR35","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.1158\/1078-0432","volume":"20","author":"NA Brown","year":"2014","unstructured":"Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao L, Lim MS, Elenitoba-Johnson KS, Betz BL (2014) Activating FGFR2-RAS-BRAF mutations in ameloblastoma. Clin Cancer Res 20(21):5517\u20135526. https:\/\/doi.org\/10.1158\/1078-0432","journal-title":"Clin Cancer Res"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-024-01743-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-024-01743-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-024-01743-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T04:53:44Z","timestamp":1767588824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-024-01743-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1743"],"URL":"https:\/\/doi.org\/10.1007\/s12105-024-01743-1","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (Protocol No. 5,148,782) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"22"}}